DAIN WAHL: Open Payments
NPI 1750336897 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,179 in 85 payments from 13 companies in 2025. Trend: 2023 $844 · 2024 $1,255 · 2025 $1,179
Food & beverage: $1,166Education: $12
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $411 |
| Novo Nordisk Inc | 12 | $168 |
| Otsuka America Pharmaceutical, Inc. | 9 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $100 |
| Lilly USA, LLC | 4 | $81 |
| Antares Pharma, Inc. | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 5 | $78 |
| Abbott Laboratories | 2 | $30 |
| Gilead Sciences, Inc. | 2 | $28 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: VRAYLAR, QULIPTA, REXULTI, CAPLYTA, MOUNJARO, XYOSTED, Ozempic, AIRSUPRA.
Industry payments across OH — which companies pay providers there.
